Z-0430-2013 Class II Terminated

Recalled by Biomerieux Inc — Hazelwood, MO

FDA device recall Z-0430-2013 was initiated by Biomerieux Inc on Oct 17, 2012 and is designated Class II. Reason for recall: The firm inventoried and distributed 0.9% Sodium Chloride Saline bags as 0.45% Sodium Chloride Saline bags for use with the VITEK 2 system. The recall status is terminated (terminated Dec 5, 2013). Affected quantity: 199 cases/14-1000mL bags.

Recall Details

Product Type
Devices
Report Date
Nov 28, 2012
Initiation Date
Oct 17, 2012
Termination Date
Dec 5, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
199 cases/14-1000mL bags

Product Description

0.9% Sodium Chloride Injections, USP, 1000ml, VWR/Baxter Product Usage: The concentrated sodium chloride is used to prepare inoculum that is analyzed by the VITEK 2 instrument. The VITEK 2 user manual instructs all users to prepare inoculum with 0.45%-0.50% sodium chloride injections, and the system is designed to use 0.45%-0.50% sodium chloride concentration only.

Reason for Recall

The firm inventoried and distributed 0.9% Sodium Chloride Saline bags as 0.45% Sodium Chloride Saline bags for use with the VITEK 2 system.

Distribution Pattern

Worldwide Distribution - USA (nationwide) including the states of: AL, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, PA, RI, TN, TX, VA and WI. Distribution was also made to Canada, military facilities and other foriegn countries.

Code Information

Lot number C866715, EXP OCT 13

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0430-2013
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.